Cite
MLA Citation
G. Galvani et al.. “MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma.” Digestive and liver disease, vol. 55, n.d., pp. S47–. http://access.bl.uk/ark:/81055/vdc_100180204345.0x000018